AI IN DRUG DISCOVERY USA
Evvnt Promotion / evvnt
21.10.2024 - 22.10.2024 Courtyard Boston Downtown, 275 Tremont Street, 02116 Boston, Massachusetts, USA
Time: 8:00 AM - 4:30 PM
Temi della conferenza
Artificial Intelligence (AI) is leading technological advancements in the pharmaceutical sector, poised to transform pre-clinical drug discovery by reducing costs by up to 40% and creating a market valued at up to $50 billion in the next decade. This transformative period is upon us, and the AI in Drug Discovery conference offers a unique opportunity to hear directly from experts and gain strategies to enhance your operations.
Artificial Intelligence (AI) is leading technological advancements in the pharmaceutical sector, poised to transform pre-clinical drug discovery by reducing costs by up to 40% and creating a market valued at up to $50 billion in the next decade. This transformative period is upon us, and the AI in Drug Discovery conference offers a unique opportunity to hear directly from experts and gain strategies to enhance your operations.
Pubblico target
The conference is ideal for companies aiming to expedite the delivery of therapeutics to patients, thereby extending healthy longevity. Attendees will learn how to build an AI ecosystem by combining internal and external resources
The conference is ideal for companies aiming to expedite the delivery of therapeutics to patients, thereby extending healthy longevity. Attendees will learn how to build an AI ecosystem by combining internal and external resources
Professional congress organizer (PCO)
SAE Media Group
SAE Media Group
Annotazioni
URL:
Brochure: https://go.evvnt.com/2449688-2?pid=4832
Speakers: DR BINO JOHN - Director, Computational Biology, Cancer Immunology and Immune Modulation, Boehringer Ingelheim, DR DMITRIY PODOLSKIY - Associate Director, Astellas Pharma, and more
URL:
Brochure: https://go.evvnt.com/2449688-2?pid=4832
Speakers: DR BINO JOHN - Director, Computational Biology, Cancer Immunology and Immune Modulation, Boehringer Ingelheim, DR DMITRIY PODOLSKIY - Associate Director, Astellas Pharma, and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/2449688-0?pid=4832
Mr. Elliot Karmel
Medicina General
Lingua
Inglese
Inglese
Quote del Congresso
AI in Drug Discovery (EARLY BIRD DISCOUNT UNTIL 09/06/24): USD 2399.00
AI in Drug Discovery (EARLY BIRD DISCOUNT UNTIL 09/06/24): USD 2399.00
I partecipanti attesi
150 - 150
150 - 150
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
